Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Duke University
Durham, North Carolina
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 116
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Stuart Knechtle | Conflict of Interest | Bristol-Myers Squibb | >$600,000 | 2019 |
| Charles Gersbach | Conflict of Interest | Editas Medicine | $200,000 - $249,999 | 2016 |
| Guillermo Sapiro | Conflict of Interest | Apple, Inc. | $100,000 - $149,999 | 2019 |
| Charles Gersbach | Conflict of Interest | Sarepta Therapeutics, Inc. | $100,000 - $149,999 | 2017 |
| Geraldine Dawson | Conflict of Interest | Apple | $100,000 - $149,999 | 2019 |
| William Gottschalk | Conflict of Interest | Zinfandel | $100,000 - $149,999 | 2014 |
| William Kirby Gottschalk | Conflict of Interest | Zinfandel | $60,000 - $79,999 | 2013 |
| William Kirby Gottschalk | Conflict of Interest | Zinfandel | $60,000 - $79,999 | 2013 |
| Michael Lutz | Conflict of Interest | Zinfandel | $60,000 - $79,999 | 2013 |
| David Weiner | Conflict of Interest | Inovio Pharmaceuticals, Inc. | $40,000 - $59,999 | 2015 |
| Michael Naughton | Conflict of Interest | Genentech | $40,000 - $59,999 | 2018 |
| Vincent Mor | Conflict of Interest | HCR | $40,000 - $59,999 | 2018 |
| Jesko Von Windheim | Conflict of Interest | Zenalux BioMedical | $20,000 - $39,999 | 2015 |
| Ashutosh Chilkoti | Conflict of Interest | Immucor, Inc. | $20,000 - $39,999 | 2017 |
| Vincent Mor | Conflict of Interest | NaviHealth, Inc | $20,000 - $39,999 | 2018 |
| Nancy Allbritton | Conflict of Interest | Cell Microsystems, Inc. | $20,000 - $39,999 | 2019 |
| Charles Gersbach | Conflict of Interest | Editas Medicine | $20,000 - $39,999 | 2016 |
| Jose Jeronimo | Conflict of Interest | Global Good | $20,000 - $39,999 | 2019 |
| Marlee Junker | Conflict of Interest | Zenalux Biomedical | $10,000 - $19,999 | 2013 |
| Angus Hucknall | Conflict of Interest | Immucor, Inc. | $10,000 - $19,999 | 2017 |
| Nirmala Ramanujam | Conflict of Interest | Zenalux Biomedical | $10,000 - $19,999 | 2015 |
| Gregory Palmer | Conflict of Interest | Zenalux Biomedical, Inc. | $10,000 - $19,999 | 2012 |
| Marlee Krieger | Conflict of Interest | Zenalux Biomedical | $10,000 - $19,999 | 2015 |
| Marlee Krieger | Conflict of Interest | Zenalux BioMedical | $10,000 - $19,999 | 2015 |
| Nirmala Ramanujam | Conflict of Interest | Zenalux Biomedical | $10,000 - $19,999 | 2015 |
| Jose Jeronimo | Conflict of Interest | Merck | $5,000 - $9,999 | 2019 |
| Mark Crowther | Conflict of Interest | Bayer | $5,000 - $9,999 | 2014 |
| William Zamboni | Conflict of Interest | Glolytics, LLC | $0 - $4,999 | 2019 |
| William Zamboni | Conflict of Interest | Glolytics, LLC | $0 - $4,999 | 2019 |
| Tatiana Segura | Conflict of Interest | Tempo Therapeutics, Inc. | $0 - $4,999 | 2019 |
| Bastiaan Driehuys | Conflict of Interest | Polarean | 2015 | |
| Annick DesJardins | Conflict of Interest | None - unlicensed IP | 2014 | |
| Darell Bigner | Conflict of Interest | Istari Oncology | 2016 | |
| Annick DesJardins | Conflict of Interest | Istari Oncology | 2017 | |
| Annick DesJardins | Conflict of Interest | Istari Oncology | 2016 | |
| Annick DesJardins | Conflict of Interest | None | 2015 | |
| Dwight Koeberl | Conflict of Interest | Actus Therapeutics | 2017 | |
| Annick DesJardins | Conflict of Interest | Istari Oncology | 2019 | |
| Darell Bigner | Conflict of Interest | Istari Oncology | 2016 | |
| Darell Bigner | Conflict of Interest | None at this time - IP is unlicensed | 2014 | |
| Wayne Matson | Conflict of Interest | CounterPoint Health Solutions, Inc. | 2014 | |
| Darell Bigner | Conflict of Interest | Istari Oncology | 2016 | |
| Priya Kishnani | Conflict of Interest | Actus Therapeutics | 2017 | |
| William Zamboni | Conflict of Interest | Glolytics, LLC | 2019 | |
| Matthias Gromeier | Conflict of Interest | None - IP is unlicensed at this time | 2014 | |
| Matthias Gromeier | Conflict of Interest | None | 2015 | |
| Darell Bigner | Conflict of Interest | Istari Oncology | 2019 | |
| Matthias Gromeier | Conflict of Interest | Istari Oncology | 2017 | |
| Matthias Gromeier | Conflict of Interest | Istari Oncology | 2016 | |
| Darell Bigner | Conflict of Interest | None | 2015 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.